Jefferies 2014 Global Healthcare Conference in London You are invited to attend the Jefferies Global Healthcare Conference on 19-20 November, 2014, at the Waldorf Hilton in London. Now in its fifth year, ours is the largest healthcare-dedicated conference in Europe. Last year, we had 230 participating healthcare companies with a combined market capitalisation of over INVITATION $1 trillion and close to 2,250 1x1/small-group meetings. The 2014 conference is set to follow 19-20 NOVEMBER 2014 in the same footsteps, featuring leading public and private companies from areas of The Waldorf Hilton pharmaceuticals, biotechnology, generics, consumer health, animal health, medical London, UK technology and healthcare services from the United States, Western and Emerging Europe, Middle East & Africa, Latin America, Russia, India, Israel, China, and Japan. This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near and long-term investment opportunities and discuss the mechanisms driving global healthcare. We hope you can join us for what promises to be a unique and comprehensive view of the industry. Registration is now open. Please email your Jefferies representative if you are interested in attending. For general questions, please email [email protected] or contact your Jefferies representative © 2014 Jefferies LLC. Member SIPC. AGENDA WEDNESDAY, NOVEMBER 19, 2014 Jefferies 2014 Global Healthcare Conference in London TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 7:30 AM Breakfast and Registration 8:00 AM EMIS Group PLC( AIM:EMIS) Auris Medical Holding AG Sartorius AG (DB:SRT) Medivation, Inc.(NasdaqGS:MDVN) Ethypharm SA (Private) Healthcare Technology (NasdaqGM:EARS) Medical Products & Devices Biotechnology Pharmaceuticals Chris Spencer, CEO Pharmaceuticals Joerg Pfirrmann, CFO David Hung, M.D., President and CEO Hugues Lecat, CEO and Chairman of the Dr. Thomas Meyer, CEO Management Board 8:40 AM Circassia Limited (LSE:CIR) Amgen Inc. (NasdaqGS:AMGN) Spectrum Pharmaceuticals, Inc. PDL BioPharma, Inc. (NasdaqGS:PDLI) Ablynx NV (ENXTBR:ABLX) Biotechnology Biotechnology (NasdaqGS:SPPI) Life Sciences Biotechnology Steven Harris, CEO Arvind Sood, Vice President of IR Biotechnology John McLaughlin, President & CEO Edwin Moses, CEO Rajesh Shrotriya, Chairman & Chief Executive Officer 9:20 AM BTG Plc (LSE:BTG) Acorda Therapeutics, Inc. Gerresheimer AG (DB:GXI) CTI BioPharma Corp. (NasdaqCM:CTIC) ReWalk Robotics Ltd. (NasdaqGM:RWLK) Biotechnology (NasdaqGS:ACOR) Medical Products & Devices Biotechnology Medical Products & Devices Louise Makin, CEO Biotechnology Mrs. Anke Linnartz, Director Corporate Jim Bianco, President and CEO Larry Jasinski, CEO Andrew Blight, Chief Scientific Officer Investor Relations & Creditor Relations 10:00 AM Hikma Pharmaceuticals plc (LSE:HIK) Swedish Orphan Biovitrum AB Henry Schein, Inc. (NasdaqGS:HSIC) Actelion Ltd. (SWX:ATLN) Flamel Technologies SA (NasdaqGM:FLML) Pharmaceuticals (OM:SOBI) Healthcare Services Biotechnology Khalid Nabilsi, CFO Pharmaceuticals Ferdinand Jahnel, VP & Treasurer Andrew Weiss, Head Investor Relations & Pharmaceuticals Corporate Communications Michael Anderson, CEO Geoff McDonough, CEO 10:40 AM Pacira Pharmaceuticals Inc. Reckitt Benckiser Pharmaceuticals GN Store Nord A/S (CPSE:GN) Cosmo Pharmaceuticals SpA uniQure N.V. (NasdaqGS:QURE) (NasdaqGS:PCRX) (Indivior)(LSE:RB.) Medical Products & Devices (SWX:COPN) Biotechnology Pharmaceuticals Michael Bjergby, Vice President - Biotechnology Jörn Aldag, CEO Pharmaceuticals Shaun Thaxter, CEO Alessandro Della Cha, CEO Jim Scibetta, Senior Vice President & CFO IR & Treasury 11:20 AM Spire Healthcare Group Plc (LSE:SPI) Novartis AG (SWX:NOVN) PerkinElmer, Inc. (NYSE:PKI) Tesaro, Inc (NasdaqGS:TSRO) Immune Design Corp. (NasdaqGM:IMDZ) Healthcare Services Pharmaceuticals Life Sciences Tools and Services Biotechnology Biotechnology Antony Mannion, Investor Relations Rainer Boehm, Chief Commercial Officer Robert Friel, Chairman and CEO Lonnie Moulder, CEO Carlos Paya, CEO Director 12:00 PM Break – Working Lunch Presenting companies and speakers are subject to change. AGENDA WEDNESDAY, NOVEMBER 19, 2014 Jefferies 2014 Global Healthcare Conference in London TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 12:20 PM Clinigen Group Plc (AIM:CLIN) Laboratorios Farmaceuticos ROVI, S.A. Panel - Trials and tribulations of emerging Pixium Vision (PIX FP) Cempra, Inc. (NasdaqGM:CEMP) Healthcare Services (CATS:ROVI) markets in the Pharma Sector Medical Technology Biotechnology Peter George, CEO Pharmaceuticals Bernard Gilly, Executive Chairman Prabhavathi Fernandes, Ph.D., Founder, Javier López-Belmonte, CFO President and CEO 1:00 PM Tissue Regenix Group Plc (AIM:TRX) Cubist Pharmaceuticals Inc. Orpea S.A. (ENXTPA:ORP) IDT Biologika GmbH (Private) Bavarian Nordic A/S (CPSE:BAVA) Medical Technology (NasdaqGS:CBST) Healthcare Services Animal Health Biotechnology Biotechnology Antony Odell, CEO Steve Grobet, Investor Relations Officer Andreas Kastenbauer, COO & Dr. Paul Chaplin, President & CEO Steve Gilman, EVP & CSO Michael Hemprich, Head of Business Development 1:40 PM Novo Nordisk A/S (CPSE:NOVO B) Novozymes A/S (CPSE:NZYM B) MAXIMUS, Inc. (NYSE:MMS) Virbac SA (ENXTPA:VIRP) Progenics Pharmaceuticals, Inc. Pharmaceuticals Pharmaceuticals Healthcare Services Animal Health (NasdaqGS:PGNX) Biotechnology Peter Kurtzhals, SVP Diabetes Research Dave Mead, Business Development Richard Montoni, CEO Eric Maree, CEO Unit Director Jim Garrison, Head of Business Development and Commercial Strategy 2:20 PM Al Noor Hospitals Group Plc (LSE:ANH) Valeant Pharmaceuticals International Recipharm AB (OM:RECI B) Aratana Therapeutics, Inc. Galapagos NV ( ENXTBR:000381835) Healthcare Services (TSX:VRX) Pharmaceuticals (NasdaqGM:PETX) Biotechnology Sami Alom, Chief Strategy Officer & Pharmaceuticals Björn Westberg, CFO Animal Health Onno Van de Stolpe, CEO Director, Investor Relations Laurie Little, SVP, Investor Relations Steve St. Peter, President and CEO 3:00 PM Medical Properties Trust (NYSE:MPW) Akorn, Inc. (NasdaqGS:AKRX) ALK-Abello (CPSE:ALK B) Putney, Inc. (Private) MediWound Ltd. (NasdaqGM:MDWD) Services Pharmaceuticals Life Sciences Animal Health Pharmaceuticals Steve Hamner, CFO Tim Dick, CFO Flemming Pedersen, CFO and EVP Jean Hoffman, Founder, Chairman and Gal Cohen, CEO Chief Executive Officer 3:40 PM Forward Pharma A/S (NasdaqGS:FWP) Ipsen S.A (ENXTPA:IPN) Neurocrine Biosciences, Inc. Parnell Pharmaceuticals Holdings Ltd. Verastem, Inc. (NasdaqGM:VSTM) Biotechnology Pharmaceuticals (NasdaqGS:NBIX) (NasdaqGM:PARN) Biotechnology Joel Sendek, CFO Marc De Garidel, CEO Biotechnology Animal Health Robert Forrester, CEO Kevin Gorman, President & CEO Robert Joseph, CEO 4:20 PM GW Pharmaceuticals plc (AIM:GWP) OpKo Health, Inc (NYSE:OPK) SciClone Pharmaceuticals, Inc. Sequent Scientific Ltd. (BSE:512529) Prosensa Holding N.V. (NasdaqGS:RNA) Pharmaceuticals Pharmaceuticals (NasdaqGS:SCLN) Animal Health Biotechnology Justin Gover, CEO Steven Rubin, Executive Vice President - Biotechnology Manish Gupta, CEO Hans Schikan, CEO Admistration Friedhelm Blobel, CEO 5:00 PM Norgine (Private) Helsinn Healthcare SA (Private) Transgene SA (ENXTPA:TNG) Pharmaceuticals Pharmaceuticals Biotechnology Peter Stein, CEO Riccardo Braglia, CEO Elisabetta Castelli, Director, Investor Relations Presenting companies and speakers are subject to change. AGENDA THURSDAY, NOVEMBER 20, 2014 Jefferies 2014 Global Healthcare Conference in London TRACK 1 TRACK 2 TRACK 3 TRACK 4 TRACK 5 ADELPHI 1 ADELPHI 2 ADELPHI 3 EXECUTIVE BOARDROOM ALDWYCH 7:30 AM Breakfast and Registration 8:00 AM Stratec Biomedical AG (DB:SBS) Vectura Group Plc (LSE:VEC) NPS Pharmaceuticals Inc. Kamada Ltd. (TASE:KMDA) Syneron Medical Ltd. (NasdaqGS:ELOS) Life Sciences Pharmaceuticals (NasdaqGS:NPSP) Biotechnology Medical Products & Devices Marcus Wolfinger, CEO Dr Chris Blackwell, CEO Biotechnology Gil Efron, CFO Hugo Goldman, CFO Francois Nader, MD, President & CEO 8:40 AM Alere Inc. (NYSE:ALR) Avalanche Biotechnologies, Inc. Haemonetics Corp (NYSE:HAE) Innate Pharma S.A. (ENXTPA:IPH) AMCo (Private) Medical Technology (NasdaqGM:AAVL) Medical Products & Devices Biotechnology Pharmaceuticals Namal Nawana, Interim CEO Biotechnology Christopher Lindop, CFO & EVP, Business Herve Brailly, CEO John Beighton, CEO Linda Bain, CFO Development 9:20 AM AMAG Pharmaceuticals, Inc. AbbVie Inc. (NYSE:ABBV) Ascendis Health Limited (JSE:ASC) ACADIA Pharmaceuticals Inc. RIEMSER Pharma GmbH (Private) (NasdaqGS:AMAG) Pharmaceuticals Pharmaceuticals (NasdaqGS:ACAD) Pharmaceuticals Pharmaceuticals Bill Chase, Executive Vice President - Dr. Karsten Wellner, CEO Biotechnology Kai Deusch, CEO Bill Heiden, CEO Chief Operating Officer Uli Hacksell, CEO 10:00 AM PT Siloam International Hospitals Tbk Roche Holding Ltd. (SWX:ROG) Nektar Therapeutics (NasdaqGS:NKTR) Dicerna Pharmaceuticals, Inc. Alvogen Group (Private) (JKSE:SILO) Pharmaceuticals Biotechnology (NasdaqGS:DRNA) Pharmaceuticals Healthcare Facilities Bill Anderson, Head of Global Product Dr. Ivan Gergel, Chief Medical Officer Biotechnology Robert Wessman, CEO Dr. Gershu Paul, CEO Strategy and Chief Marketing Officer James Dentzer, CFO Kevin Bain, CFO 10:40 AM Abiomed Inc. H. Lundbeck A/S (CPSE:LUN) Kite Pharma, Inc. (NasdaqGS:KITE) Compugen Ltd. (NasdaqCM:CGEN) Doc Generici S.R.L. (Private) (NasdaqGS:ABMD)